Plinda Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally divided into two doses daily regardless of food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose is 150 mg daily and can be increased to 300 mg daily within 3 to 7 days, then increased to a maximum of 600 mg at 7-day intervals. - Central Neuropathic Pain: Starting dose is 150 mg daily, which can be increased to 300 mg daily after 1 week,

Child dose

Safety and efficacy data for children under 12 years old and adolescents aged 12-17 are insufficient, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if any symptoms of depression or mood changes occur, it should be reported to a healthcare provider immediately. This medication should not be taken if there is hypersensitivity to it or specific genetic lactose-related disorders. Diabetes patients may be affected in blood sugar control due to weight gain, and adjustments in the dosage of blood sugar medications may be necessary. If symptoms of angioedema occur, discontinue the medication immediately, and caution is required in the elderly due to the risk of accidents from dizziness or drowsiness. Visual changes such as blurred vision may occur, and if any abnormal symptoms arise, consulting a healthcare provider is necessary. Discontinuing this medication abruptly may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually after consulting a specialist. Patients with a history of drug abuse may have a higher risk of misuse of this medication, so it should be used cautiously. Patients with heart disease or impaired renal function should use this medication with caution, as concurrent use with opioid analgesics increases the risk of central nervous system depression. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant should consult a doctor and use effective contraception. Women who are breastfeeding should carefully assess whether to breastfeed due to the possibility of this medication being transmitted through breast milk and the necessity of treatment. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness fully subsides. This medication may cause serious skin reactions, so if any skin abnormalities such as rashes or blisters appear, discontinue use immediately and inform a healthcare provider. In the event of overdose, symptoms such as confusion, drowsiness, and depression may occur, and hemodialysis may be required if necessary. Keep this medication out of reach of children and avoid transferring it to other containers.

Serious side effects

Hives, severe swelling, angioedema, facial swelling, periorbital swelling, upper respiratory tract swelling, chest tightness, difficulty breathing, cold sweat, paling, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities associated with coughing and fever, jaundice, yellowing of skin or eyes, profound lethargy, symptoms of liver dysfunction,

Mild side effects

• Confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization
• abnormal sexual sensations
• restlessness

This medicine should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept in a cool place between 15 and 30 degrees Celsius. Storing it this way will help maintain the efficacy of the medication.

Appearance

Hard capsules with a reddish-brown upper part and a white lower part containing white powder

Package unit

30 capsules/bottle, 60 capsules/bottle